2,3-bisphosphoglycerate Mutase (BPGM) Peptide
BPGM
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BPGM products
- BPGM (2,3-bisphosphoglycerate Mutase (BPGM))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BPGM antibody (Catalog #: ARP58217_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BPGM (2,3-bisphosphoglycerate Mutase (BPGM))
- Background
-
BPGM belongs to the phosphoglycerate mutase family, BPG-dependent PGAM subfamily. It plays a major role in regulating hemoglobin oxygen affinity as a consequence of controlling 2,3-BPG concentration. It can also catalyze the reaction of EC 5.4.2.1 (mutase) and EC 3.1.3.13 (phosphatase), but with a reduced activity.
Alias Symbols: DPGM
Protein Interaction Partner: GAPDH
Protein Size: 259 - Molecular Weight
- 28 kDa
- Gene ID
- 669
- NCBI Accession
- NM_001724, NP_001715
- UniProt
- P07738
-
You are here:
